Sunburn Clinical Trial
Verified date | February 2009 |
Source | Loreal USA |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Food and Drug Administration |
Study type | Interventional |
The purpose of this study is to determine the safety potential of Helioblock® SX Cream as a sunscreen product in long term intermittent use conditions among pediatric subjects.. Each subject will be enrolled to participate for six months. The test product should be applied every day that outdoor activities are planned, prior to any significant sun exposure during out-door activities (such as the beach, outdoor sport activities), or whenever the subject needs to be protected against sunburn or other damage due to the sun. A minimum of 14 days test product use and sun exposure is required.
Status | Completed |
Enrollment | 0 |
Est. completion date | November 2006 |
Est. primary completion date | November 2006 |
Accepts healthy volunteers | |
Gender | Both |
Age group | 6 Months to 12 Years |
Eligibility |
Inclusion Criteria: - Male or female subjects of any race or skin type, 6 months to 12 years of age inclusive, willing to use the test product intermittently for six months during outside activities Exclusion Criteria: - Subjects with known sensitivities to any of the study ingredients or subjects with a condition or in a situation, which in the Investigator's opinion, may suggest a significant hazard for the subject, may confound the study results, or interfere with the subject's participation in the study. - Subjects who are pregnant or lactating |
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
United States | Research Testing Laboratories | Great Neck | New York |
Lead Sponsor | Collaborator |
---|---|
Loreal USA |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Long term safety after 6 months intermittent use in a pediatric population | 6 months | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00206882 -
The Sun Protection Effect and Efficacy in Treatment of Sunburn Using Topical Corticosteroids.
|
N/A | |
Completed |
NCT05767008 -
Water Immersion Studies of a Long-wear Sunscreen to Improve Protection Against Ultraviolet Radiation
|
N/A | |
Completed |
NCT00441051 -
Efficacy and Safety of Diclofenac Sodium (0.1%) Gel in Patients With UV Induced Painful Sunburn
|
Phase 3 | |
Completed |
NCT01873430 -
The Sun Protective Effect of Melatonin
|
Phase 1 | |
Completed |
NCT03199573 -
Hats on Head Start: A A Survey of Sun Protection Behaviors in Head Start and Other Early Childhood Education Programs
|
N/A | |
Terminated |
NCT03332524 -
Clinical Trial of the Safety and Efficacy of SP160412 in the Temporary Relief of Mild to Moderate Sunburn
|
Phase 2 | |
Completed |
NCT03752736 -
Sun Safety Skills for Elementary School Students
|
N/A | |
Completed |
NCT05260359 -
Dermal Irritation, Sensitization and Cumulative Irritation Potential of 6% Bemotrizinol
|
Phase 2 | |
Completed |
NCT01021787 -
Dermal Penetration of the Titanium Dioxide in Anthelios SX SPF40 Cream
|
Phase 4 | |
Completed |
NCT03607578 -
Test of Interventions to Prevent Skin Cancer Among Danes on Vacation in High UV Index Sunny Destinations
|
N/A | |
Completed |
NCT03489356 -
Project Options - The ABC Method
|
N/A | |
Enrolling by invitation |
NCT03007589 -
Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics
|
N/A | |
Not yet recruiting |
NCT01085851 -
Non-inferiority Clinical Trial of Dexchlorpheniramine (Cream Versus Lotion) in the Relief of Sunburn Related Symptoms
|
Phase 3 | |
Not yet recruiting |
NCT01237925 -
Non-inferiority Clinical Trial of Dexchlorpheniramine (Cream Versus Gel) in the Relief of Sunburn Related Symptoms
|
Phase 3 |